Russia is preparing to provide hospitals with a coronavirus drug developed with the sovereign wealth fund’s backing after gaining initial approval from the Health Ministry amid a global race to find safe and effective treatments for Covid-19.
The medicine will be shipped to hospitals starting June 11 and exports may follow once domestic demand is met, according to the Russian Direct Investment Fund, which is producing the antiviral in a joint venture with the ChemRar Group.
The treatment, Avifavir, is based on a generic version of Fujifilm Holdings Corp.’s drug Avigan, which Japan’s government is still looking to approve for treatment of coronavirus. Final-stage clinical trials of Russia’s Avifavir involving 330 patients are continuing, according to the wealth fund.
As the coronavirus continues to spread, upending economies and life around the world, drug companies have been racing to develop treatments and vaccines. Clinical trials showed Avifavir helped reduce the number of days a person is infected and cut the period of high fever, according to the RDIF.
Don’t let the MSM censor your news as America becomes Great Again. Over 500,000 Americans receive our daily dose of life, liberty and pursuit of happiness along with Breaking News direct to their inbox—and you can too. Sign up to receive news and views from The 1776Coalition!
We know how important your privacy is and your information is SAFE with us. We’ll never sell
your email address and you can unsubscribe at any time directly from your inbox.